Inside Collection: Biochemistry Exercises
Summary: Final exam for all Carbohydrate and Nitrogen lectures.
| 1. Which of the following molecules CANNOT be excreted by the kidneys as glucuronides? | |
| A. | Bile (stercobilin) |
| B. | Progesterone |
| C. | Bilirubin diglucuronide |
| D. | Morphine |
| E. | Thyroid hormone |
| 2. Which of the following molecules DOES NOTaccumulate in bloodas a result of a defect in any of the enzymes of the urea cycle? | |
| A. | Any of the intermediates of the urea cycle |
| B. | Ammonia in the form of NH4+ |
| C. | Glutamine and alanine |
| D. | All the intermediates of glycolysis |
| 3. Which of the following hormones regulates the excretion of both water and sodium counteracting the effects of other water homeostasis hormones? | |
| A. | Aldosterone |
| B. | Antidiuretic hormone |
| C. | Cortisol |
| D. | Estrogen |
| E. | Natriuretic peptides |
| 4. Which of the following digestive enzymes pairs can break peptide bonds at either terminal end of a polypeptide? | |
| A. | Trypsin & chymotrypsin |
| B. | Elastase & collagenase |
| C. | Aminopeptidase and carboxypeptidase |
| D. | Dipeptidase & tripeptidase |
| E. | Enterokinase and Phospholipase A |
| 5. Which of the following enzymes pairs can perform autocatalysis once they are activated? | |
| A. | Pepsin & trypsin |
| B. | Aminopeptidase & carboxypeptidase |
| C. | Elastase & collagenase |
| D. | Dipeptidase & tripeptidase |
| E. | Chymotrypsin & Phospholipase A |
| 6. Which of the following zymogens can help in the screening of gastric disorders? | |
| A. | Trypsinogen |
| B. | Pepsinogen |
| C. | Chymotrypsinogen |
| D. | Procollagenase |
| E. | Procarboxypeptidase |
| 7. Which of the following disorders can affect the release of pancreatic digestive enzymes into the intestinal lumen? | |
| A. | Hartnup disease |
| B. | Cystinuria |
| C. | Cystic fibrosis |
| D. | Atrophic gastritis |
| E. | Duodenal ulcer |
| 8. Which of the following mechanisms facilitates the absorption and release of hydrophobic amino acids into the body's cells? | |
| A. | Aquaporins |
| B. | Autophagosomes |
| C. | Secondary active transporters |
| D. | Simple diffusion |
| E. | Facilitated diffusion |
| 9. Which of the following statements about the degradation of body's proteins is INCORRECT? | |
| A. | Proteins for degradation are recognized based on the presence of ubiquiting tags, PEST sequences, N-terminal or oxidized residues. |
| B. | A single ubiquitin isopeptide assigns a regulatory function to a protein but multiple ubiquitin isopeptides targets the protein for degradation. |
| C. | E1 binds and transfer an ubiqutin molecule to E2 and E3 joins the ubiquitin from E2 to the end terminal end of a target protein. |
| D. | Lysosomal proteases break down body' proteins into polypeptides; while, proteasome complexes break them into single amino acids. |
| E. | Binding of N-acetylglucosamine to the active sites of the proteasome inhibits protein degradation and the removal of this molecule facilitates protein degradation. |
| 10. Which of the following digestive enzymes pairs can break peptide bonds at either terminal end of a polypeptide? | |
| A. | Trypsin & chymotrypsin |
| B. | Elastase & collagenase |
| C. | Aminopeptidase and carboxypeptidase |
| D. | Dipeptidase & tripeptidase |
| E. | Enterokinase and Phospholipase A |
| 11. Which of the following enzymes pairs need to be activated via autocatalysis? | |
| A. | Pepsin & lysosomal proteases |
| B. | Aminopeptidase & carboxypeptidase |
| C. | Elastase & collagenase |
| D. | Dipeptidase & tripeptidase |
| E. | Chymotrypsin & Phospholipase A |
| 12. Which of the following zymogens can help in the screening of some gastrointestinal cancers? | |
| A. | Trypsinogen |
| B. | Pepsinogen |
| C. | Chymotrypsinogen |
| D. | Procollagenase |
| E. | Procarboxypeptidase |
| 13. Which of the following disorders will not cause a deficiency of essential amino acids due to either the lack of pancreatic digestive enzymes in the intestinal lumen or defective amino acid transporters? | |
| A. | Hartnup disease |
| B. | Cystic fibrosis |
| C. | Cystinuria |
| D. | Pancreatitis |
| 14. A patient is diagnosed with emphysema. Which of the following enzymes is responsible for the damage to the lungs? | |
| A. | Elastase |
| B. | Collagenase |
| C. | Carboxypeptidase |
| D. | Chymotrypsin |
| E. | Trypsin |
| 15. Which of the following systems can break body’s proteins into single amino acids? | |
| A. | A 19S cap with a 20S proteasome. |
| B. | A 19S cap, 20S proteasome and 11S cap |
| C. | A 20S proteasome with an 11S cap |
| D. | Lysosomal proteases |
| 16. Which of the following defective enzyme pairs can produce altered branching in the glycogen molecule? | |
| A. | Glycogen synthase and glucose-6-phosphatase |
| B. | Musle and liver glycogen phosphorylase |
| C. | Glucorynyl transferase and phosphoglucomutase |
| D. | Glycogenin and alanine aminotransferase |
| E. | Branching and debranching enzymes |
| 17. A patient develops kidney failure and skin rashes. A tissue biopsy reveals accumulation of globotriocylceramide. Which of the following defective enzymes can cause Fabry's disease? | |
| A. | Acid-beta-glucosidase |
| B. | Alpha-galactosidase A |
| C. | Acid ceramidase |
| D. | Beta-galactosidase-1 |
| E. | Galactocerebrosidase |
| 18. Which of the following hormones binds beta receptors in both the liver and muscle cells to stimulate glycogenolysis via cAMP signal transduction? | |
| A. | Glucagon |
| B. | Epinephrine |
| C. | Cortisol |
| D. | Insulin |
| E. | Aldosterone |
| 19. Which of the following molecules would be present in high concentrations in the meconium of neonates or premies with jaundice? | |
| A. | Conjugated bilirubin |
| B. | Urobilinogen |
| C. | Stercobilin |
| D. | Unconjugated bilirubin |
| E. | Urobilin |
| 20. Which of the following actions stimulates the release of calcium as part of the signal cascade in the liver to activate glycogenolysis and inhibit glycogenesis? | |
| A. | Epinephrine binding to beta receptors |
| B. | Epinephrine binding to alpha receptors |
| C. | Glucagon binding to liver receptors |
| D. | Degradation of ATP to AMP |
| E. | Neural impluses on muscle cells |
| 21. Which of the following defective enzymes can cause accumulation of both galactose and galactitol? | |
| A. | UDP-galactose-4-epimerase |
| B. | Galactokinase |
| C. | Galactose-1-phosphate uridyltransferase |
| D. | Galactose-6-phosphatase |
| E. | Phosphoglucomutase |
| 22. Which of the following organ or tissues cells can convert glucose to lactate for spermatogenesis? | |
| A. | Muscle cells |
| B. | Renal cells |
| C. | Red blood cells |
| D. | Sertoli cells |
| E. | Astrocytes |
| 23. A patient has mental retardation, enlarged liver and skeletal abnormalities. Tissue biopsy reveals accumulation of GM1 gangliosides in neurons. Which of the following defective enzymes can cause GM1 gangliosidosis? | |
| A. | Acid-beta-glucosidase |
| B. | Alpha-galactosidase A |
| C. | Acid ceramidase |
| D. | Beta-galactosidase-1 |
| E. | Galactocerebrosidase |
| 24. A 25 year old female, previously diagnosed with Gilbert's syndrome, has hyperbilirubinemia as a result of eating a very low calorie diet. Which of the following treatments would be effective in dealing with her hyperbilirubinemia? | |
| A. | Iron supplements |
| B. | Antiviral drugs |
| C. | Cholecystectomy |
| D. | No treatment |
| E. | Steroid drugs |
| 25. Which of the following enzymes converts glucose-1-phosphate into glucose-6-phosphate during glycogen degradation? | |
| A. | Glycogen synthase |
| B. | Glycogen phosphorylase |
| C. | Phosphoglucomutase |
| D. | Branching enzyme |
| E. | Debranching enzyme |
| 26. Which of the following hormones is important in both the activation and synthesis of the enzymes involved in glycogenesis inside the liver and muscle cells? | |
| A. | Glucagon |
| B. | Epinephrine |
| C. | Norepinephrine |
| D. | Vasopressin |
| E. | Insulin |
| 27. Which of the following enzymes transfers galactose from UDP-galactose to glucose in the mammary glands? | |
| A. | Galactosyl transferase |
| B. | Alpha-lactalbumin |
| C. | Phosphoglucomutase |
| D. | Glucose-6-phosphatase |
| E. | Galactose-1-phosphate uridyltransferase |
| 28. Which of the following enzymes can increase the risk of developing cancer and its activity can be blocked with glucaric acid? | |
| A. | Hexaminidase A |
| B. | Arylsulfatase A |
| C. | Acid ceramidase |
| D. | Beta-glucuronidase |
| E. | Beta-galactosidase-1 |
| 29. Which of the following statements BEST describes glycogenesis? | |
| A. | Glycogenesis is regulated via three hormones: glucagon, epinephrine and cortisol. |
| B. | The branching enzyme adds 8 -12 glucose molecules to the glycogenin primer. |
| C. | Glycogen synthase adds glucose molecules via alpha-1, 4-O-glycosidic bonds. |
| D. | UDP-glucuronate is the precursor molecule for building the structure of glycogen. |
| E. | Insulin activates the enzymes involved in the release of glucose from glycogen. |
| 30. A 35-year old man has the following symptoms: extreme weigh loss, an enlarged liver, right upper quadrant pain and tenderness, and a yellow tinge to his skin especially in the sclera of the eyes. Laboratory test results shows: Urinalysis (dipstick): Urine Urobilinogen: 8 mg/dL (Normal Range: 0.2 - 1 mg/dL)Urine Bilirubin: Present (Measured as positive or negative for presence in urine)Blood Analysis:Alanine aminotransferase (ALT): 50 U/L (Normal Range 5 - 40 U/L)Alkaline Phosphatase(ALP): 110 U/L (Normal Range < 140 U/L)Direct Bilirubin: 0.5 mg/dL (Normal Range 0.1 - 0.3 mg/dL)Indirect Bilirubin: 1.0 mg/dL (Normal Range 0.2 - 0.8 mg/dL)Blood IgM Anti-HAV antibodies: PositiveBlood IgG Anti-HAV antibodies: NegativeProlonged Prothrombin time (PT) even with vitamin K administrationWhich of the following liver disorders is consistent with these laboratory results? | |
| A. | Sickle cell anemia |
| B. | Hepatitis A |
| C. | Biliary obstruction |
| D. | Physiological jaundice |
| E. | Pathological jaundice |
| 31. Which of the following statements is a common misconception about diabetes insipidus? | |
| A. | Central diabetes insipidus is caused by damage to the posterior pituitary. |
| B. | Disease shows high concentration of glucose in both urine and blood. |
| C. | Nephrogenic diabetes insipidus is caused by genetic mutations. |
| D. | Patients can lose up to 16 liters of urine per day causing severe dehydration. |
| E. | Characteristic symptoms include polydipsia for cold water and polyuria. |